Researchers at GIGA have developed a murine graft-versus-myeloma (GVM) model by combining an immunocompetent myeloma model and a chronic graft-versus-host (GVH) disease model. This model is currently used for further studies aiming at dissociating GVM and GVH effect.

Contact [] us to discuss how these capabilities can forward your projects! We will help you develop tailored solutions.